MEGHAN DEMATTA: Open Payments
NPI 1609351055 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 19 payments from 9 companies in 2025. Trend: 2023 $765 · 2024 $589 · 2025 $520
Food & beverage: $460Education: $60
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $245 |
| GENZYME CORPORATION | 3 | $104 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $40 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 2 | $27 |
| Phadia US Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Stryker Corporation | 1 | $15 |
| PhotoniCare Inc | 1 | $15 |
Products named: DUPIXENT, NEFFY, INSPIRE, TEZSPIRE, ImmunoCAP, Rhapsido, AUDION ET DILATION SYSTEM, OtoSight Middle Ear Scope.
Industry payments across NC — which companies pay providers there.
